Alantolactone inhibits cervical cancer progression by downregulating BMI1

Alantolactone inhibits cervical cancer progression by downregulating BMI1

Abstract Cervical cancer is the second most common cancer in women. Despite advances in cervical cancer therapy, tumor recurrence and metastasis remain the leading causes of mortality. High expression of BMI1 is significantly associated with poor tumor differentiation, high clinical grade, and poor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiaodong Sun, Hongxia Xu, Tianyu Dai, Lixia Xie, Qiang Zhao, Xincai Hao, Yan Sun, Xuanbin Wang, Nan Jiang, Ming Sang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/62aa2beeff9b416299876423bba6445c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares